Literature DB >> 7418318

The cellular basis of bone resorption.

T J Chambers.   

Abstract

The osteoclast is the major agent of bone resorption. Durang the last few years persuasive evidence has emerged from several sources which shows that the osteoclast is derived from the fusion of cells of the mononuclear phagocyte system. This fact makes a reevaluation of the pathophysiology of bone resorption necessary. The most plausible mechanism for osteoclast formation is that bone-lining alter bone locally in such a way as to lead to its phagocytic recognition by mononuclear phagocytes. These cells then accumulate on the altered bone surface, commence digestion, and fuse in a similar way to that shown for other macrophage polykaryons. Once formed, osteoclast function may be influenced in two ways: some agents, such as osteoclast-activating factor and lipopolysaccharide, may directly stimulate osteoclast resorptive activity, in the same way as they influence the activity of other cells of the mononuclear phagocyte system; other agents, such as parathormone and prostaglandins, because they also cause in increase in the number of osteoclasts, seem more likely to have a primary effect on bone-lining cells, which in turn regulate osteoclast activity by unknown mechanisms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418318

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  46 in total

1.  Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo.

Authors:  D L Lacey; H L Tan; J Lu; S Kaufman; G Van; W Qiu; A Rattan; S Scully; F Fletcher; T Juan; M Kelley; T L Burgess; W J Boyle; A J Polverino
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

Authors:  N A Athanasou; J Quinn
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

3.  Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas.

Authors:  H A Kulenkampff; T Dreyer; W Kersjes; G Delling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Use of monoclonal antibodies to recognise osteoclasts in routinely processed bone biopsy specimens.

Authors:  N A Athanasou; B Puddle; J Quinn; C G Woods
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

Review 5.  Historically significant events in the discovery of RANK/RANKL/OPG.

Authors:  T John Martin
Journal:  World J Orthop       Date:  2013-10-18

6.  Bone homeostasis.

Authors:  G A Rodan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

7.  The role of macrophages and giant cells in loosening of joint replacement.

Authors:  U E Pazzaglia; J A Pringle
Journal:  Arch Orthop Trauma Surg       Date:  1988

Review 8.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

9.  Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.

Authors:  R J van't Hof; A C Tuinenburg-Bol Raap; P J Nijweide
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

Review 10.  Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit.

Authors:  Natalie A Sims; T John Martin
Journal:  Bonekey Rep       Date:  2014-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.